A Study to Evaluate Single-dose of HB0043 in Healthy Adult Participants

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 3, 2025

Primary Completion Date

December 1, 2025

Study Completion Date

April 1, 2026

Conditions

Healthy

Interventions

DRUG

HB0043

HB0043 Drug Product

DRUG

Placebo

Trial Locations (1)

RECRUITING

New Zealand Clinical Research , Grafton, Auckland, 3 Ferncroft Street,, Auckland

All Listed Sponsors

lead

Shanghai Huaota Biopharmaceutical Co., Ltd.

INDUSTRY